Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome

Clinical Immunology

Volumn 132, Issue 1, 2009, Pages 124-131

  Cheng, Laurence E ^a   Kanwar, Bittoo ^a   Tcheurekdjian, Haig ^a   Grenert, James P ^a   Muskat, Mica ^a   Heyman, Melvin B ^a   McCune, Joseph M ^a   Wara, Diane W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Colitis; Enteritis; IKK ; Immunodeficiency; Inflammatory bowel disease; NEMO; NF B

Indexed keywords

AZITHROMYCIN; BUDESONIDE; GLUCOCORTICOID; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN; MARKER; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN; PREDNISONE; SULFAMETHOXAZOLE; TAZOBACTAM; TRIMETHOPRIM; VANCOMYCIN;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM INFECTION; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; ENTEROCOLITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; MALE; MENINGITIS; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT COMPLIANCE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; TOPICAL TREATMENT; TREATMENT DURATION;

ADOLESCENT; BLOOD SEDIMENTATION; CHILD; CHILD, PRESCHOOL; COLONOSCOPY; ENTEROCOLITIS; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFLAMMATION; MALE; PEDIGREE;

EID: 67349203943     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.03.514     Document Type: Article

References (34)

1. Puel A., Picard C., Ku C.L., Smahi A., and Casanova J.L. Inherited disorders of NF-kappaB-mediated immunity in man. Curr. Opin. Immunol. 16 (2004) 34-41
2. Orange J.S., Levy O., and Geha R.S. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol. Rev. 203 (2005) 21-37
3. Ku C.L., Yang K., Bustamante J., Puel A., von Bernuth H., Santos O.F., Lawrence T., Chang H.H., Al-Mousa H., Picard C., and Casanova J.L. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev. 203 (2005) 10-20
4. Yang F., Yamashita J., Tang E., Wang H.L., Guan K., and Wang C.Y. The zinc finger mutation C417R of I-kappa B kinase gamma impairs lipopolysaccharide- and TNF-mediated NF-kappa B activation through inhibiting phosphorylation of the I-kappa B kinase beta activation loop. J. Immunol. 172 (2004) 2446-2452
5. Jain A., Ma C.A., Lopez-Granados E., Means G., Brady W., Orange J.S., Liu S., Holland S., and Derry J.M. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. J. Clin. Invest. 114 (2004) 1593-1602
6. von Bernuth H., Puel A., Ku C.L., Yang K., Bustamante J., Chang H.H., Picard C., and Casanova J.L. Septicemia without sepsis: inherited disorders of nuclear factor-kappa B-mediated inflammation. Clin. Infect. Dis. 41 Suppl. 7 (2005) S436-S439
7. Sivakumar V., Hammond K.J., Howells N., Pfeffer K., and Weih F. Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development. J. Exp. Med. 197 (2003) 1613-1621
8. Schmidt-Supprian M., Courtois G., Tian J., Coyle A.J., Israel A., Rajewsky K., and Pasparakis M. Mature T cells depend on signaling through the IKK complex. Immunity 19 (2003) 377-389
9. + regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4566-4571
10. Sachar D.B., Luppescu N.E., Bodian C., Shlien R.D., Fabry T.L., and Gumaste V.V. Erythrocyte sedimentation as a measure of Crohn's disease activity: opposite trends in ileitis versus colitis. J. Clin. Gastroenterol. 12 (1990) 643-646
11. Vila L.M., Alarcon G.S., McGwin Jr. G., Bastian H.M., Fessler B.J., and Reveille J.D. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J. Rheumatol. 32 (2005) 2150-2155
12. Zonana J., Elder M.E., Schneider L.C., Orlow S.J., Moss C., Golabi M., Shapira S.K., Farndon P.A., Wara D.W., Emmal S.A., and Ferguson B.M. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am. J. Hum. Genet. 67 (2000) 1555-1562
13. Makris C., Roberts J.L., and Karin M. The carboxyl-terminal region of IkappaB kinase gamma (IKKgamma) is required for full IKK activation. Mol. Cell. Biol. 22 (2002) 6573-6581
14. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.F., Gasche C., Geboes K., Jewell D.P., Karban A., Loftus Jr. E.V., Pena A.S., Riddell R.H., Sachar D.B., Schreiber S., Steinhart A.H., Targan S.R., Vermeire S., and Warren B.F. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 19 Suppl. A (2005) 5-36
15. Satsangi J., Silverberg M.S., Vermeire S., and Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55 (2006) 749-753
16. Orange J.S., Jain A., Ballas Z.K., Schneider L.C., Geha R.S., and Bonilla F.A. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J. Allergy Clin. Immunol. 113 (2004) 725-733
17. Tatara R., and Imai H. Serum C-reactive protein in the differential diagnosis of childhood meningitis. Pediatr. Int. 42 (2000) 541-546
18. Korppi M., Heiskanen-Kosma T., and Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur. Respir. J. 10 (1997) 1125-1129
19. Robertson J., Shilkofski N., and Johns Hopkins Hospital. Children's Medical and Surgical Center., The Harriet Lane handbook: a manual for pediatric house officers (2005), Elsevier Mosby, Philadelphia, PA
20. Arkwright P.D., Abinun M., and Cant A.J. Autoimmunity in human primary immunodeficiency diseases. Blood 99 (2002) 2694-2702
21. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340 (1999) 448-454
22. Uzel G. The range of defects associated with nuclear factor kappaB essential modulator. Curr. Opin. Allergy Clin. Immunol. 5 (2005) 513-518
23. Matsumoto S., Okabe Y., Setoyama H., Takayama K., Ohtsuka J., Funahashi H., Imaoka A., Okada Y., and Umesaki Y. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43 (1998) 71-78
24. Xavier R.J., and Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007) 427-434
25. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev., Immunol. 2 (2002) 725-734
26. Hanson E.P., Monaco-Shawver L., Solt L.A., Madge L.A., Banerjee P.P., May M.J., and Orange J.S. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J. Allergy Clin. Immunol. 122 (2008) 1169-1177 e16
27. Clark A.R. Anti-inflammatory functions of glucocorticoid-induced genes. Mol. Cell. Endocrinol. 275 (2007) 79-97
28. Present D.H., Rutgeerts P., Targan S., Hanauer S.B., Mayer L., van Hogezand R.A., Podolsky D.K., Sands B.E., Braakman T., DeWoody K.L., Schaible T.F., and van Deventer S.J. Infliximab for the treatment of fistulas in patients with Crohn's disease. N. Engl. J. Med. 340 (1999) 1398-1405
29. Bayless T.M. Maintenance therapy for Crohn's disease. Gastroenterology 110 (1996) 299-302
30. Luengo-Blanco M., Prando C., Bustamante J., Aragao-Filho W.C., Pereira P.V., Rehder J., Padden C., Casanova J.L., Newburger P.E., and Condino-Neto A. Essential role of nuclear factor-kappaB for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes. Blood 112 (2008) 1453-1460
31. Macdonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 (2005) 1920-1925
32. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M.F., and Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446 (2007) 557-561
33. Torgerson T.R. Regulatory T cells in human autoimmune diseases. Springer Semin. Immunopathol. 28 (2006) 63-76
34. Greten F.R., Arkan M.C., Bollrath J., Hsu L.C., Goode J., Miething C., Goktuna S.I., Neuenhahn M., Fierer J., Paxian S., Van Rooijen N., Xu Y., O'Cain T., Jaffee B.B., Busch D.H., Duyster J., Schmid R.M., Eckmann L., and Karin M. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130 (2007) 918-931